Navigation Links
War on cancer produces collateral damage to the heart
Date:9/21/2010

Philadelphia, PA, September 21, 2010 For the past two decades, cancer therapy has become more sophisticated and effective, resulting in an ever-expanding group of long-term cancer survivors. There is also a growing awareness of the potentially negative effects of cancer treatment on the heart and the management of cardiac disease during and after cancer therapy. In the September/October issue of Progress in Cardiovascular Diseases an international group of experts takes an in-depth look at the ways in which cancer treatment profoundly impacts patients' cardiovascular function and can become a major detriment of overall survival.

Guest Editors of this issue, Douglas L. Mann, MD, and Ronald J. Krone, MD, both of the Division of Cardiology, Washington University School of Medicine, St. Louis, put the situation into perspective. "The management of heart disease in all its forms in patients with cancer in all its forms presents special challenges to the cardiologist. In the war on cancer, the cardiologist is not in the front lines, directly confronting the enemy, but in the role of support and supply, providing the oncologist the ability to keep the warrior strong enough to defeat the enemy. In fighting the war on cancer, there is, like in any war, unwanted 'collateral damage.' There is no 'silver bullet' but, in many ways, a refined shotgun, blasting the tumor while pellets hit other vital organs. The bone marrow, liver, and nervous system get their share of hits; but the heart and vascular system are certainly at risk depending on the weapon used, particularly because the vascular system and blood supply are intimately involved in any treatment delivery. Just as in a war, not only must the enemy be destroyed; but the damage must be contained to permit the rebuilding of the homeland."

This issue of Progress in Cardiovascular Disease was inspired by the very successful third International Symposium of the Cardiology Oncology Partnership, which was held in September 2009 in Milan, Italy. This meeting marked the inauguration of the International Cardioncology Society, an international society responding to the need for cooperation between these medical disciplines.

"The recent recognition of the frequent collateral damage of the heart from many of the newer chemotherapeutic agents, as well as the classic anthracyclines, and the importance of this to management of the cancer, should spur the acquisition of cardiac outcomes data and ultimately trigger the development of specific evidence-based practice guidelines to keep the heart from interfering with the war on cancer," commented Dr. Mann and Dr. Krone.


'/>"/>

Contact: Katrina Saling
k.saling@elsevier.com
215-239-3712
Elsevier Health Sciences
Source:Eurekalert

Related medicine news :

1. Cholesterol drug may have role in treating prostate cancer
2. Mayo-led researchers discover genetic variants modifying breast cancer risk
3. 4 possible risk factors for ovarian cancer found
4. 2 studies find new genetic links to ovarian cancer risk
5. New Drug Promising for Advanced Thyroid Cancer
6. Better marker for breast cancer may reduce need for second surgeries
7. Targeted therapy decreases progression rate in thyroid cancer
8. Prostate cancer community calls for better early detection and treatment
9. MIT researchers discover an unexpected twist in cancer metabolism
10. Scott & White Healthcare to participate in international trial investigating lung cancer treatment
11. Low-Dose Aspirin May Reduce Colon Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... CA (PRWEB) , ... January 24, 2017 , ... Learn ... studies, work, athletics or even in relationships. Course offered by Dr. Carol Francis ... necessary due to limited seating and the many hands-on experiences. , Dr. ...
(Date:1/24/2017)... PA (PRWEB) , ... January 24, 2017 , ... ... advocacy company, announced today that its annual Solutions Series of webinars will start ... industry thought leaders discussing a number of current health and benefits topics, including ...
(Date:1/24/2017)... (PRWEB) , ... January 24, 2017 , ... Bellus Medical, ... company’s team of medical experts. In his new role Dr. Dobke will provide physician ... , Dr. Dobke is the Head of Plastic Surgery and Associate Professor of Surgery ...
(Date:1/24/2017)... ... January 24, 2017 , ... Providing solutions ... new report from the Frank Hawkins Kenan Institute of Private Enterprise ... academics and policy makers identified concrete solutions at the “What’s Next, America?” conference ...
(Date:1/24/2017)... , ... January 24, 2017 , ... The results from ... for everyone and particularly good news for prostate cancer patients: incidents of cancer is ... According to the report the cancer death rate has dropped from its peak of ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... January 24, 2017 www.Financialbuzz.com ... industries in the United States as ... 2016. In addition, Proposition 64, the California Cannabis Legalization Initiative, ... against on November 8, 2016. This outcome means that individuals ... and to grow a certain amount of cannabis for personal ...
(Date:1/24/2017)... , Jan. 24, 2017   QR Pharma ... company developing novel therapies for the treatment of ... the appointment of four world-class key opinion leaders ... appointments join QR Pharma,s previous roster of impressive ... direction to support the development of the breakthrough ...
(Date:1/24/2017)... 2017 Mezzion has filed a suit for ... alleging that Dr. Reddy,s committed fraud relating to Dr. ... Administration (FDA) cGMP practices, and misrepresenting its compliance to ... to Mezzion that it was compliant with FDA regulations, ... suit also states that Dr. Reddy,s misconduct was the ...
Breaking Medicine Technology: